
Investor Relations Captor Therapeutics ®
Content of resolutions adopted by the Extraordinary General Meeting
Current report no. 15/2025
Date of preparation: 24 February 2025
Subject: Content of resolutions adopted by the Extraordinary General Meeting
Legal basis: Article 56(1)(2) of the Act on Offering - current and periodic information
The Management Board of Captor Therapeutics S.A., with its registered office in Wrocław (the “Company”), hereby provides the contents of the resolutions adopted by the Extraordinary General Meeting of the Company on 24 February 2025 (the “EGM”).
At the same time, the Company informs that the EGM did not waive consideration of any of the items on the planned agenda. There were no objections to the adopted resolutions.
Detailed legal basis:
§19 para. 1 pt. 6 of the Regulation of the Minister of Finance of 29 March 2018 on current and periodic information provided by issuers of securities and the conditions for recognising as equivalent the information required by the laws of a non-member state.